Goal: To provide an overview of depressive symptoms in patients with end stage renal disease and therapeutic interventions to improve outcomes.
Define depression in ESRD.
Describe the two pathways associated with depression in patients with ESRD.
Explain the consequences of inflammation and depressive symptoms in patients with ESRD.
Identify ways depression may compromise a patient's adherence to treatment regimens.
Statement of Disclosure: The authors reported no actual or potential conflict of interest in relation to this continuing nursing education article.
Acknowledgment: This work was supported in part by a Center grant to the University of Kentucky College of Nursing from NIH, NINR, 1P20NR010679. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Nursing Research or the National Institutes of Health.